IPOs in global biopharma industry surge to USD 8.52 billion in 2024: Report MD Bureau21 April 2025 12:30 PM ISTNew Delhi: The biopharmaceutical sector saw a notable resurgence in 2024, with initial public offerings (IPOs) soaring 68.4% globally to reach $8.52...
Court Removes Injunction on Sun Pharma's LEQSELVI Launch in US Farhat Nasim10 April 2025 6:05 PM ISTDelhi: In a major relief to Sun Pharmaceutical Industries Ltd, the U.S. Court of Appeals for the Federal Circuit has vacated a preliminary injunction...
'Golden time for India to emerge as innovator nation in biopharma sector' Ruchika Sharma23 Jun 2022 3:30 PM ISTWashington: Post COVID19, it's a golden time for India to emerge as an innovator nation in the biopharma sector, organiser of the annual India-US...
IQVIA Biotech launches in Asia Pacific, Japan Medical Dialogues Team27 May 2021 10:30 AM ISTNew Delhi: With the goal of substantial clinical development, IQVIA recently announced the Japan and Asia Pacific (JAPAC) expansion of IQVIA Biotech,...
CDSCO panel nod to phase 3 trials of Sputnik V by Hetero Pharma Medical Dialogues Team30 April 2021 3:50 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has given a green signal to Hetero...
Industry leaders, Govt officials eye global collaboration in pharma sector Farhat Nasim31 Aug 2020 2:48 PM ISTNew Delhi: The need of global collaboration in the pharma sector from research and development to drug manufacturing has never been as great as it is...
J&J signs deal with Chinese drugmaker for hepatitis B drug savita thakur thakur9 Jan 2016 12:42 PM ISTJohnson & Johnson said it licensed rights from a Chinese drugmaker to drugs that spur the immune system to help fight diseases, which it hopes...
